FDA considering ketamine-based drug for depression
Thursday, August 18, 2016 - 14:11
in Health & Medicine
Stephen FellerWASHINGTON, Aug. 18 (UPI) -- The FDA granted breakthrough status to speed the development of esketamine, a ketamine-based drug for depression patients, according to the manufacturer.